In accordance with the Drug Dependence (Treatment not Imprisonment) (Amendment) Act, 2018, synthetic cannabinoid products and medicinal preparations of the plant cannabis products licenced under the Medicines Act or manufactured under Good Manufacturing Practice (GMP), may be prescribed by all licenced medical practitioners, if it is considered that there is no viable alternative to such prescription.
SPH Circular 2/2018 Prescribing and Dispensing of Medical Cannabinoids
Request for Approval for Prescribing of Medical Cannabinoid by a Licensed Medical Practitioner
Drug Dependence (Treatment not Imprisonment) Act (Chapter 537)